文献速递传染病防控与疫情报告免疫规划

2010-11至2024-25流感季美国流感相关死亡儿童中脑病报告

Reports of Encephalopathy Among Children with Influenza-Associated Mortality - United States, 2010-11 Through 2024-25 Influenza Seasons.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2025-02-27

CDC分析了2010-11至2024-25流感季1840例流感相关儿童死亡,其中166例(9%)有流感相关脑病或脑炎(IAE),各季比例0%至14%,2024-25季截至2025年2月8日初步数据为68例中9例(13%)有IAE。因无专门国家监测,尚不知本季病例数是否偏离预期。建议对急性发热伴神经系统症状持续>24小时的儿童考虑IAE,并评估流感检测、神经影像及早期抗病毒治疗。

要点

  • 2010-11至2024-25季1840例流感相关儿童死亡中166例(9%)有IAE。
  • 2024-25季截至2025年2月8日初步数据68例中9例(13%)有IAE。
  • 对急性发热伴神经系统症状持续>24小时儿童应考虑IAE并检测流感。

核心结论

  • 因无专门国家监测,尚不知2024-25季IAE或急性坏死性脑病(ANE)病例数是否偏离预期。
  • 医务人员应结合流感检测、神经影像及早期抗病毒治疗评估疑似IAE患儿。

研究设计与样本

  • CDC分析2010-11至2024-25流感季报告的流感相关儿童死亡中IAE比例趋势及病例特征。
  • CDC联系州卫生部门核实2024-25季报告的IAE死亡病例是否同时诊断ANE。

主要发现

  • 2010-11至2024-25季1840例流感相关儿童死亡中166例(9%)有IAE,各季比例0%(2020-21季)至14%(2011-12季)。
  • 2024-25季截至2025年2月8日初步数据68例中9例(13%)有IAE。
  • 跨季致命IAE患者中位年龄6岁,54%无基础疾病,仅20%接种过流感疫苗。

临床怎么用

  • 对急性发热伴神经系统体征或症状持续>24小时的儿童应考虑IAE。
  • 评估应包括流感及其他病毒检测和神经影像。
  • 临床管理应包括对疑似或确诊流感的早期抗病毒治疗及必要的支持性重症监护。
  • 所有≥6月龄符合条件者只要流感病毒在传播就推荐接种流感疫苗。

局限性

  • 因无专门国家监测,尚不知本季IAE或ANE病例数是否偏离预期。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In late January 2025, CDC received anecdotal reports of children with influenza-associated acute necrotizing encephalopathy (ANE), a severe form of influenza-associated encephalopathy or encephalitis (IAE), including several fatal cases. In response, CDC examined trends in the proportions of cases with IAE among influenza-associated pediatric deaths reported during the 2010-11 through 2024-25 influenza seasons, including demographic and clinical characteristics of identified cases. CDC contacted state health departments to ascertain whether any pediatric influenza-associated deaths with IAE reported this season also had a diagnosis of ANE. Among 1,840 pediatric influenza-associated deaths during the 2010-11 through 2024-25 influenza seasons, 166 (9%) had IAE, ranging from 0% (2020-21 season) to 14% (2011-12 season); preliminary data for the 2024-25 season (through February 8, 2025) indicate that nine of 68 (13%) had IAE. Across seasons, the median age of patients with fatal IAE was 6 years; 54% had no underlying medical conditions, and only 20% had received influenza vaccination. Because no dedicated national surveillance for IAE or ANE exists, it is unknown if the numbers of cases this season vary from expected numbers. Health care providers should consider IAE in children with acute febrile illness and neurologic signs or symptoms lasting >24 hours. Evaluation should include testing for influenza and other viruses and neuroimaging; clinical management should include early antiviral treatment for suspected or confirmed influenza and supportive critical care management as needed. Influenza vaccination is recommended for all eligible persons aged ≥6 months as long as influenza viruses are circulating.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Fazal A, Reinhart K, Huang S, et al. Reports of Encephalopathy Among Children with Influenza-Associated Mortality - United States, 2010-11 Through 2024-25 Influenza Seasons. MMWR Morb Mortal Wkly Rep. 2025. PMID: 40014654. doi:10.15585/mmwr.mm7406a3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。